Carcinoid

Results: 237



#Item
1

PDF Document

Add to Reading List

Source URL: www.carcinoid.org

- Date: 2017-12-04 10:58:08
    2ORIGINAL ARTICLE Clinical Value of Monitoring Plasma Octreotide Levels During Chronic Octreotide Long-Acting Repeatable Therapy in Carcinoid Patients Eugene A. Woltering, MD, FACS,* Vergilio A. Salvo, MD,* Thomas M. O_D

    ORIGINAL ARTICLE Clinical Value of Monitoring Plasma Octreotide Levels During Chronic Octreotide Long-Acting Repeatable Therapy in Carcinoid Patients Eugene A. Woltering, MD, FACS,* Vergilio A. Salvo, MD,* Thomas M. O_D

    Add to Reading List

    Source URL: www.interscienceinstitute.com

    Language: English - Date: 2009-09-25 15:15:22
    3JOBNAME: pan 31#PAGE: 1 OUTPUT: Wednesday October 19 08:24:lww/panMPA200087 ORIGINAL ARTICLE Effect of Octreotide LAR Dose and Weight on Octreotide

    JOBNAME: pan 31#PAGE: 1 OUTPUT: Wednesday October 19 08:24:lww/panMPA200087 ORIGINAL ARTICLE Effect of Octreotide LAR Dose and Weight on Octreotide

    Add to Reading List

    Source URL: www.interscienceinstitute.com

    Language: English - Date: 2009-09-25 15:15:26
    4ORIGINAL ARTICLE Validation of Serum Versus Plasma Measurements of Chromogranin A Levels in Patients With Carcinoid Tumors Lack of Correlation Between Absolute Chromogranin A Levels and Symptom Frequency

    ORIGINAL ARTICLE Validation of Serum Versus Plasma Measurements of Chromogranin A Levels in Patients With Carcinoid Tumors Lack of Correlation Between Absolute Chromogranin A Levels and Symptom Frequency

    Add to Reading List

    Source URL: www.interscienceinstitute.com

    Language: English - Date: 2012-12-06 13:48:28
    5ORIGINAL ARTICLE Development of a Highly Sensitive and Specific Carboxy-Terminal Human Pancreastatin Assay to Monitor Neuroendocrine Tumor Behavior Thomas M. O’Dorisio, MD,* Siegfried R. Krutzik, PhD,Þ Eugene A. Wolt

    ORIGINAL ARTICLE Development of a Highly Sensitive and Specific Carboxy-Terminal Human Pancreastatin Assay to Monitor Neuroendocrine Tumor Behavior Thomas M. O’Dorisio, MD,* Siegfried R. Krutzik, PhD,Þ Eugene A. Wolt

    Add to Reading List

    Source URL: www.interscienceinstitute.com

    Language: English - Date: 2010-07-13 17:09:37
    6Neuro- Endocriene Tumoren (NET) WHO 2010 classificatie Voorwoord Neuroendocriene tumoren, vroeger carcinoïd genoemd, zijn een groep van zeldzame tumoren,

    Neuro- Endocriene Tumoren (NET) WHO 2010 classificatie Voorwoord Neuroendocriene tumoren, vroeger carcinoïd genoemd, zijn een groep van zeldzame tumoren,

    Add to Reading List

    Source URL: www.net-kanker.nl

    Language: Dutch - Date: 2012-06-04 07:49:35
      7Mixed large cell neuroendocrine carcinoma and adenocarcinoma of the gallbladder: a case report and brief review of the literature

      Mixed large cell neuroendocrine carcinoma and adenocarcinoma of the gallbladder: a case report and brief review of the literature

      Add to Reading List

      Source URL: www.wjso.com

      Language: English
      8PRESS RELEASE Start of Pivotal Phase III trial for Lutathera® in cancer patients with progressive midgut carcinoid Highlights ∑

      PRESS RELEASE Start of Pivotal Phase III trial for Lutathera® in cancer patients with progressive midgut carcinoid Highlights ∑

      Add to Reading List

      Source URL: www.adacap.com

      - Date: 2015-01-10 03:25:53
        9ENETS Guidelines Neuroendocrinology 2009;90:220–226 DOI: Received: August 27, 2008 Accepted after revision: January 27, 2009

        ENETS Guidelines Neuroendocrinology 2009;90:220–226 DOI: Received: August 27, 2008 Accepted after revision: January 27, 2009

        Add to Reading List

        Source URL: www.enets.org

        Language: English - Date: 2010-03-29 03:41:48
        10ENETS Consensus Guidelines Neuroendocrinology 2012;95:120–134 DOI: Published online: February 15, 2012

        ENETS Consensus Guidelines Neuroendocrinology 2012;95:120–134 DOI: Published online: February 15, 2012

        Add to Reading List

        Source URL: www.enets.org

        Language: English - Date: 2012-08-30 10:04:38